Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV gB Vaccine in Transplant Candidates
NCT00299260Phase 2Unknown
- Sponsor
- University College London
- Start
- Aug 2006
- Primary completion
- Sep 2009
- Countries
- 1
01
Overview
A Phase 2 trial of cytomegalovirus subunit vaccine glycoprotein B in cytomegalovirus infection (CMV), sponsored by University College London. Status: unknown.
02
Drugs
cytomegalovirus subunit vaccine glycoprotein B
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00299260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299260.